Qlucore AB (QCORE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Qlucore AB (QCORE) has a cash flow conversion efficiency ratio of -0.194x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.04 Million ≈ $-757.94K USD) by net assets (Skr36.30 Million ≈ $3.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Qlucore AB stock valuation for the company's overall valuation and market capitalisation.
Qlucore AB - Cash Flow Conversion Efficiency Trend (2019–2026)
This chart illustrates how Qlucore AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Qlucore AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qlucore AB ranked by their cash flow conversion efficiency. Explore how high is Qlucore AB's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Savannah Resources Plc
LSE:SAV
|
-0.033x |
|
Alexium International Group Limited
F:E7T
|
-0.087x |
|
PSYCHED WELLNESS LTD
F:5U9
|
-0.323x |
|
Monarca Minerals Inc
V:MMN
|
0.008x |
|
Webus International Limited Ordinary Shares
NASDAQ:WETO
|
0.240x |
|
NTR Holding A/S
CO:NTR-B
|
-0.080x |
|
Eagle Eye Solutions Group plc
LSE:EYE
|
0.125x |
|
Focusrite Plc
LSE:TUNE
|
0.145x |
Annual Cash Flow Conversion Efficiency for Qlucore AB (2019–2026)
The table below shows the annual cash flow conversion efficiency of Qlucore AB from 2019 to 2026. View Qlucore AB (QCORE) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-04-30 | Skr36.30 Million ≈ $3.91 Million |
Skr-12.46 Million ≈ $-1.34 Million |
-0.343x | -41.81% |
| 2025-04-30 | Skr58.47 Million ≈ $6.29 Million |
Skr-14.15 Million ≈ $-1.52 Million |
-0.242x | -13.00% |
| 2024-04-30 | Skr79.11 Million ≈ $8.51 Million |
Skr-16.95 Million ≈ $-1.82 Million |
-0.214x | -152.16% |
| 2023-04-30 | Skr94.73 Million ≈ $10.19 Million |
Skr-8.05 Million ≈ $-866.20K |
-0.085x | -38.02% |
| 2022-04-30 | Skr110.56 Million ≈ $11.90 Million |
Skr-6.81 Million ≈ $-732.43K |
-0.062x | -108.40% |
| 2021-04-30 | Skr36.56 Million ≈ $3.93 Million |
Skr-1.08 Million ≈ $-116.23K |
-0.030x | -126.46% |
| 2020-04-30 | Skr14.34 Million ≈ $1.54 Million |
Skr1.60 Million ≈ $172.29K |
0.112x | -40.31% |
| 2019-04-30 | Skr8.56 Million ≈ $921.47K |
Skr1.60 Million ≈ $172.29K |
0.187x | -- |
About Qlucore AB
Qlucore AB (publ) offers visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. It offers Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a software platform for m… Read more